Microderm
Drug - Microderm
The trade name of the product as shown on the labeling.
Dosage -
SPONGE; TOPICAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Chlorhexidine Gluconate
Multiple ingredients are in alphabetical order.
Strength -
4%
The potency of the active ingredient(s), Chlorhexidine Gluconate. May repeat for multiple part products.
Applicant -
J AND J
The firm name holding legal responsibility for Microderm. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
072295
The FDA assigned number to Microderm. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Microderm. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Feb 28, 1991
The date Microderm was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of Microderm. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
OTC
The group or category of approved drugs Microderm is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Johnson And Johnson Medical Inc
The full name of the firm holding legal responsibility for the new application of Microderm.
Microderm
|
